Trends in oncology drug lags in Japan from 2001 to 2020: A cross‐sectional study

Abstract Anticancer drugs are essential in the treatment of serious diseases, but their applications are limited by drug lags. This study investigated the characteristics of anticancer drugs approved in Japan over the past 20 years and compared the drug lag trends between Japan and the US. We assess...

Full description

Bibliographic Details
Main Authors: Hideki Maeda, Asuka Hara, Momoka Ofuchi, Riko Shingai, Toshihiro Misumi, Yuna Murai
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13660